| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |